Consistently, mice with specific deletion for β-catenin in CD11c+ cells exhibit reduced numbers of IL-10-producing Tregs intratumorally, which is associated with enhanced anti-tumor CD4 and CD8 T cell response (Zhao et al., 2018a). Here, CD8A is linked to neoplasm.